Visamundi
Asia

Philippines update eTravel for Mpox screening at borders

The Philippines strengthen entry screening via updated eTravel forms to detect Mpox (formerly monkeypox) and curb cross-border spread of the clade Ib strain. All travelers must now disclose symptoms or exposure risks.

The Philippine government has rolled out enhanced border health controls to prevent the introduction and spread of Mpox (formerly monkeypox) within its territory. These measures form part of a broader strengthened epidemiological surveillance strategy in response to rising Mpox cases reported across multiple countries.

Updated eTravel form checks Mpox risk

Screening questions added to entry requirements

Following the example set by Nigeria and Indonesia, the Philippine Department of Health (DOH) has updated the mandatory eTravel form for all incoming and outgoing travelers to include targeted Mpox screening questions. The move is intended to flag potential cases of the clade Ib strain, which is considered more virulent.

Complete your eTravel including Mpox questions

The revised form now asks travelers whether they have experienced symptoms within 30 days prior to travel. Where symptoms are reported, the updated drop-down menu includes the option: “rash, blisters or sores.” The DOH urges travelers to provide truthful responses to these questions.

The eTravel app is available on mobile (iOS and Android) and desktop

Screening and next steps

Automated alert system triggers follow-up

Travelers flagged as having recently arrived from Mpox-affected countries, been exposed to confirmed cases, or showing clinical symptoms trigger an automatic alert on etravel.gov.ph. The alert is sent directly to the Bureau of Immigration and the DOH Bureau of Quarantine (DOH-BOQ).

Secondary screening protocol

Once flagged, travelers undergo a more detailed secondary assessment. If this confirms a suspected Mpox case, the individual is immediately transferred to a designated referral hospital for specialist care.

Current Mpox situation in the Philippines

The DOH has confirmed two new cases since its last update, bringing the national total to 14 since July 2022. Only five cases remain active at present. All identified infections to date belong to the Mpox clade II, which is considered less virulent than clade I.

Comparing Mpox clade characteristics

The table below outlines key differences between Mpox virus clades.

Characteristic

MPXV clade I

MPXV clade II

Geographic origin

Central Africa

West Africa

Case fatality rate

1% to 10%

<1% to 4%

Transmissibility

High

Moderate

Clinical severity

More severe

Less severe

Cases in Philippines

0

14

Who the new rules apply to

The enhanced screening applies to all travelers, including overseas Filipino workers (OFWs), tourists, and foreign nationals—both on entry and exit. The DOH strongly advises travelers to complete the updated eTravel form accurately and honestly. If in doubt about health status, especially after visiting areas considered Mpox risk zones, travelers are encouraged to consult a physician before departure.

The Philippines is collaborating closely with neighboring ASEAN countries to align border controls and share real-time epidemiological data. This regional approach aims to present a unified front against potential Mpox spread across Southeast Asia.

Auteur
Anna Dennis

Spécialiste de la veille réglementaire et experte en contenus destinations, elle analyse quotidiennement l’évolution des formalités d’entrée pour traduire la complexité administrative en guides pratiques. Son rôle combine expertise terrain et précision technique afin de garantir la fiabilité des informations délivrées aux voyageurs.

Countries

Weekly newsletter

Entry formalities, decoded every week

Visas, ETAs, arrival cards, passports: get the essential travel-tech news in your inbox, once a week.

By subscribing, you agree to receive our emails. You can unsubscribe at any time via the link in every message.